Skip to content

Home Visits for Patients at Risk for Appointment No-shows

SNAP HOME: Smart No-show Analytics Paired With Home-based Outpatient Medical Engagement

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04376736
Acronym
SNAP HOME
Enrollment
0
Registered
2020-05-06
Start date
2019-09-01
Completion date
2023-07-01
Last updated
2023-07-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Utilization, Health Care, Engagement, Patient, No-Show Patients

Brief summary

Unused clinic visits due to patient no-shows continue to plague American healthcare as a large source of waste and avoidable constraint on access. The average no-show rate across 105 studies was 23% though with wide variation (4% to 79%). No-show behavior has adverse effects on patients, providers, and healthcare organizations' operational and financial outcomes. Patients that miss clinic visits are more likely to need acute care and suffer poor health outcomes. There have been increasingly sophisticated efforts focused on predicting which patients are likely to no-show. This can allow for tactful over-booking and/or patient outreach. At Hopkins, investigators have implemented a novel machine learning based approach for identifying those patients at high-risk for no-show. Offering home visits for patients who are most likely to no-show is an appealing strategy to connect medical providers with patients who need care but are otherwise unlikely to receive it. Yet, it is unclear if this would be helpful to engage patients in their care, and encourage subsequent attendance, or if it would encourage future missed appointments, fostering a reliance on possible ongoing home visits. This study would link existing efforts with no-show prediction to home visits by internal medicine residents and evaluate its clinical impact. Patients at high-risk for no-show will be randomized into the control arm where patients will be called to remind patients of their visits. Those randomized into the intervention arm will be offered a one time home visit in lieu of their in-person visit to help understand barriers to in-person care and build rapport. Outcomes evaluated include future in-person show rates and healthcare cost/utilization

Interventions

Home visit by medical provider

Sponsors

Johns Hopkins University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* One or more poorly controlled chronic medical illness * More than one chronic illness, regardless of its level of control * Acute illness

Exclusion criteria

* No documented medical illnesses (acute or chronic) * Single well controlled chronic illness

Design outcomes

Primary

MeasureTime frameDescription
Engagement1 year post enrollmentSubsequent show up rate for medical clinic appointments, that is, number of actual visits per total number of expected visits

Secondary

MeasureTime frameDescription
Healthcare utilization as assessed by number of hospitalizations1 year post enrollmentThis will be assessed based on the Number of ER visits and hospitalizations

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026